Connaughton Bernadette
SEC CIK 1662521 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | Dir | 40.4K | — | $1.28M | 15 | 2022-05-05 | 2026-08-10 |
Most active insiders at HALO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Torley Helen | Pres AND CEO, Dir | — | $39.85M |
| 2 | Caudill Cortney | SVP, COO | — | $2.23M |
| 3 | Posard Matthew L. | Dir | — | $2.05M |
| 4 | Connaughton Bernadette | Dir | — | $989.9K |
| 5 | Krishnan Mahesh | Dir | — | $547.8K |
| 6 | LaBrosse Nicole | SVP, CFO | — | — |
| 7 | Snyder Mark Howard | SVP, CLO | — | — |
| 8 | Appelhans Dannielle | Dir | — | — |
| 9 | Lang James Paul | Dir | — | — |
| 10 | DUNCAN BARBARA GAYLE | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-11 17:43 | 2026-08-10 | HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Dir | S - Sale | $102.80 | -1,626 | 40.4K | -4% | -$167.2K |
| MT | 2026-07-02 16:42 | 2026-07-01 | HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Dir | S - Sale | $76.71 | -1,625 | 42.0K | -4% | -$124.7K |
| T | 2026-06-02 17:20 | 2026-06-01 | HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Dir | S - Sale | $66.21 | -1,625 | 43.7K | -4% | -$107.6K |
| D | 2026-05-07 19:01 | 2026-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Dir | A - Grant | $0.00 | +6,796 | 45.3K | +18% | $0 |
| T | 2026-05-05 17:05 | 2026-05-01 | HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Dir | S - Sale | $63.48 | -1,625 | 38.5K | -4% | -$103.2K |
| 2026-01-06 | 2026-01-05 | HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Dir | S - Sale | $70.25 | -2,000 | 40.1K | -5% | -$140.5K | |
| 2025-12-01 | 2025-12-01 | HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Dir | S - Sale | $71.60 | -829 | 42.1K | -2% | -$59.4K | |
| 2025-11-12 | 2025-11-10 | HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Dir | S - Sale | $68.48 | -2,000 | 43.0K | -4% | -$137.0K | |
| M | 2025-10-01 | 2025-10-01 | HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Dir | S - Sale | $75.24 | -2,000 | 45.5K | -4% | -$150.5K |
| M | 2025-09-02 | 2025-09-02 | HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Dir | S - Sale | $73.69 | -4,000 | 50.9K | -7% | -$294.7K |
| D | 2025-05-02 | 2025-05-01 | HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Dir | A - Grant | $0.00 | +4,165 | 51.0K | +9% | $0 |
| D | 2024-04-29 | 2024-04-25 | HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Dir | A - Grant | $0.00 | +6,501 | 46.8K | +16% | $0 |
| D | 2023-05-09 | 2023-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Dir | A - Grant | $0.00 | +8,065 | 40.3K | +25% | $0 |
| 2022-11-17 | 2022-11-16 | HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Dir | G - Gift | $0.00 | -5,998 | 32.2K | -16% | $0 | |
| 2022-05-06 | 2022-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Dir | A - Grant | $0.00 | +6,206 | 38.2K | +19% | $0 |
Purchase Sale Sale after option exercise All abbreviations